Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
Go back to Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 12.24 +0.17 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.07 | 52 Week High | $135.54 | |||
| Open | $12.13 | 52 Week Low | $94.36 | |||
| Day High | $12.34 | P/E | N/A | |||
| Day Low | $12.13 | EPS | $0.00 | |||
| Volume | 296,432 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 49.06 +1.06 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.00 | 52 Week High | $135.00 | |||
| Open | $48.00 | 52 Week Low | $94.95 | |||
| Day High | $49.06 | P/E | N/A | |||
| Day Low | $49.06 | EPS | $0.00 | |||
| Volume | 745 | |||||



